Role of the Bp 35 cell surface polypeptide in human B-cell activation ( B lymphocytes / proliferation / monoclonal antibodies )
E. Clark,G. Shu,J. Ledbetter
Abstract:A 35-kDa polypeptide, Bp35, expressed on the surface of all B cells, plays a role in B-cell activation. Monoclonal antibodies to Bp35 stimulate human tonsillar B cells to proliferate. The activation induced by anti-Bp35 is similar to anti-Ig-inediated in several ways: the activation does not require T cells but is augmented by T-cell-derived allogeneic factors; monovalent Fab fragments to Bp35 do not trigger proliferation but instead block activation by whole antibody, indicating that cross-linking is required; and induction by anti-Bp35, like the induction by anti-Ig, is inhibited by monoclonal anti-IgM via an Fc domain-dependent mechanism. However, several features of anti-Bp35-mediated proliferation are clearly different from activation by anti-Ig: anti-Bp35 monoclonal antibodies do not require attachment to beads to function, the proliferation induced by anti-Bp35 and anti-Ig is additive, and Fab fragments of anti-Bp35 augment proliferation induced by anti-Ig. Models for the possible function of the Bp35 polypeptide as either a "bridge" or a "second signal" with surface Ig in B-cell activation are discussed. B lymphocytes can be stimulated to proliferate by relatively high concentrations of antisera specific for surface immunoglobulin (Ig) receptors (1-4). Low doses of anti-Ig, which alone do not stimulate B cells to divide, can, in the presence of T-cell-derived B-cell stimulatory factors (BSF), induce substantial proliferation (5-7). A current model is that, after an initial activation signal (e.g., by low doses of anti-,u heavy chain antisera), receptors are expressed for accessory cellderived growth and differentiation factors such as BSF and interleukin 1 (IL-1); in the presence of these factors, B cells divide and differentiate (6-9). Although specific receptors for the T-cell growth factor interleukin 2 (IL-2) have been characterized (10), analogous structures on B cells have yet to be fully elucidated. Recently, a number of new polypeptides on B cells have been identified with monoclonal antibodies (mAb) (refs. 11-14, 35, 36). One antigen, Bp35, a 35-kDa polypeptide first defined by the mAb B1 (12), is only expressed on cells of the B-cell lineage (12, 14, 35). Bp35 is a phosphoprotein expressed at high density on germinal-center B cells (15, 16). Recently, we have found that Bp35 is expressed at higher levels on B cells able to proliferate in response to T-cell factors and at lower levels on resting B cells not able to respond to growth factors without other signals (36). Here we show that the Bp35 molecule plays some role in B-cell activation: anti-Bp35 antibodies alone trigger resting tonsillar B cells to proliferate. This proliferation is enhanced by T-cell factors and is distinct from proliferation triggered through surface IgM. MATERIALS AND METHODS Antibodies. The monoclonal antibodies used in this study have been described (14) or will be described elsewhere. They include 2H7 (IgG2b) and 1F5 (IgG2a) mAbs specific for Bp35 (CD20), which block the binding of each other and thus are specific for the same epitope or a closely related epitope; HB1Oa (IgG2b) mAb specific for HLA-DR; 2C3 (IgG1) and 4B8 (IgG2a) specific for IgM; 9BA5 (IgG2b) specific for the p55 55-kDa B-cell associated antigen; and H616 (IgG2a) specific for the p76 76-kDa B-cell surface antigen. Purification of mAbs and conjugation with fluorescein, using fluorescein-5-isothiocyanate (17), or with R-phycoerythrin, using 3-(2-pyridylthio)propionic acid N-hydroxysuccinimide ester (18), for oneand two-color cytofluorographic analysis as detailed elsewhere (37). mAbs were conjugated to CNBractivated Sepharose 4B beads (Pharmacia) at a ratio of 10 mg/ml of Sepharose. Fab fragments of the iF5 and 2C3 antibodies were prepared by papain digestion followed by separation on a protein A-Sepharose or Sephacryl S-200 (Pharmacia) to remove undigested antibody and Fc fragments. Antibodies or Fab fragments were dialyzed extensively against phosphate-buffered saline prior to use in cell-culture experiments. Cell Preparations. Tonsillar cell suspensions were prepared by teasing tissue gently in R15 (RPMI 1640 medium with penicillin, streptomycin, glutamine, pyruvate, and 15% fetal bovine serum). Lymphocytes in tonsillar cell suspensions or lymphocytes in heparinized blood diluted 1:2 in R15 were isolated using Lymphocyte Separation Medium (Litton Bionetics). Cells were washed twice, resuspended in 30%o Percoll at 108 cells per ml and layered over Percoll (Pharmacia) step gradients (19) in 15-ml conical tubes with 2.5 ml of 60%, 55%, 50%, 45%, and 40% Percoll. After centrifugation at 3000 x g for 5 min, cells from the 45/50 (Fxl), 50/55 (Fx2), and 55/60 (Fx3) interfaces and the pellet were isolated and tested. Cell Cultures. Cells were cultured in quadruplicate in 96-well Microtiter plates in 200 ,A of R15 at 106 cells per ml. After 1-7 days, cells were incubated with 0.5 ,uCi of [3H]thymidine per well (New England Nuclear, 6.7 Ci/mmol; 1 Ci = 37 GBq). After 18-24 hours, cells were harvested onto glass-fiber filters with a cell harvester, and radioactivity was measured in a liquid scintillation counter. For a source of T-cell factors, T cells were cultured for 2 days with mitomycin C-treated allogeneic cells. These mixed lymphocyte reaction-derived T-cell factors (MLR-TF) were used at a concentration of 12.5%-50% (19, 20). Flow Cytometry. Flow cytometry with a modified FACS IV cell sorter (Becton Dickinson) and quantitative two-color Abbreviations: BSF, B-cell-stimulating factor(s); mAb, monoclonal antibody; MLR-TF, mixed lymphocyte reaction-derived T-cell factors (i.e., allogeneic T-cell supernatant). *To whom reprint requests should be addressed, at Dept. of Microbiology and Immunology, University of Washington SC-42, Seattle, WA 98195. 1766 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Proc. Natl. Acad. Sci. USA 82 (1985) 1767 analyses are described elsewhere (35-37). In brief, 5 x 105 cells were incubated for 30 min on ice with fluoresceinand/or phycoerythrin-conjugated mAb, washed twice, and passed through fine gauze just before analysis. A 488-nm laser line was used, and a 560-nm dichroic mirror (Becton Dickinson) split the emission wavelengths. Additional 580-nm longpass and 540-nm short-pass filters (Ditric Optics, Hudson, MA) were placed in front of the red (phycoerythrin) and green (fluorescein) photomultiplier tubes, respectively. A compensator built by T. Nozaki (Stanford University) was used to correct any residual spillover of green and red signals.